Medicenna Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Apr '25 Apr 25, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	2015 - 2019
Market Capitalization	84	130	61	92	270	168	Upgrade
Market Cap Growth	341.25%	111.36%	-33.17%	-66.08%	60.46%	675.67%	Upgrade
Enterprise Value	54	108	25	68	237	161	Upgrade
Last Close Price	1.07	1.86	0.88	1.65	5.11	3.60	Upgrade
PB Ratio	4.82	24.95	2.08	4.40	7.09	4.66	Upgrade
P/TBV Ratio	4.83	25.23	2.08	4.42	7.10	4.67	Upgrade
Debt / Equity Ratio	0.01	-	-	-	0.00	0.00	Upgrade
Quick Ratio	9.90	1.30	4.95	8.33	9.93	20.80	Upgrade
Current Ratio	10.09	1.37	5.23	8.92	10.26	20.86	Upgrade
Return on Equity (ROE)	-149.09%	-146.88%	-39.94%	-76.56%	-46.54%	-42.70%	Upgrade
Return on Assets (ROA)	-42.09%	-42.00%	-34.02%	-42.75%	-27.10%	-23.87%	Upgrade
Return on Capital (ROIC)	-64.43%	-67.31%	-40.50%	-47.60%	-29.23%	-26.54%	Upgrade
Earnings Yield	-31.99%	-19.66%	-16.40%	-24.62%	-6.40%	-4.91%	Upgrade
FCF Yield	-19.47%	-12.55%	-20.65%	-25.72%	-5.66%	-3.21%	Upgrade
Buyback Yield / Dilution	-7.07%	-7.57%	-19.25%	-9.31%	-55.68%	-24.25%	Upgrade

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.